| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| CVS - CVS Health Corp | HOLD | 0 @ USD 67.46 | USD 0 | The current share valuation price of CVS based on adjusted close was USD 67.46. The average price that CVS shares were previous bought at was USD 62.9223. The current market price is 7.2% higher than average price they were purchased at. The value of the holding in CVS has increased by USD 653,978 compared to the previous valuation of CVS Health Corp however if the holding was sold on 2025-06-13 this would crystalise an overall loss. |
| DVA - DaVita HealthCare Partners Inc | SELL | -50 @ USD 136.12 | USD -6,806 | The ETF sold 50 shares of DVA on 2025-06-13. The shares were previously bought for an average price of USD 154.347. The DaVita HealthCare Partners Inc shares were sold for -11.8% lower than average price of previous purchases. This resulted in an overall loss of USD 911 The average price that the ETF previously sold DVA share for is USD 152.8 which is higher than the selling price of USD 136.12 on 2025-06-13. |
| CRL - Creightons Plc | SELL | -56 @ USD 149.45 | USD -8,369 | The ETF sold 56 shares of CRL on 2025-06-13. The shares were previously bought for an average price of USD 168.232. The Creightons Plc shares were sold for -11.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,052 The average price that the ETF previously sold CRL share for is USD 186.404 which is higher than the selling price of USD 149.45 on 2025-06-13. |
| TECH - Bio-Techne Corp | SELL | -174 @ USD 50.52 | USD -8,790 | The ETF sold 174 shares of TECH on 2025-06-13. The shares were previously bought for an average price of USD 65.0058. The Bio-Techne Corp shares were sold for -22.3% lower than average price of previous purchases. This resulted in an overall loss of USD 2,521 The average price that the ETF previously sold TECH share for is USD 69.5182 which is higher than the selling price of USD 50.52 on 2025-06-13. |
| HSIC - Henry Schein Inc | SELL | -138 @ USD 70.19 | USD -9,686 | The ETF sold 138 shares of HSIC on 2025-06-13. The shares were previously bought for an average price of USD 72.8322. The Henry Schein Inc shares were sold for -3.6% lower than average price of previous purchases. This resulted in an overall loss of USD 365 The average price that the ETF previously sold HSIC share for is USD 71.1235 which is higher than the selling price of USD 70.19 on 2025-06-13. |
| MRNA - Moderna Inc | SELL | -368 @ USD 26.67 | USD -9,815 | The ETF sold 368 shares of MRNA on 2025-06-13. The shares were previously bought for an average price of USD 35.3915. The Moderna Inc shares were sold for -24.6% lower than average price of previous purchases. This resulted in an overall loss of USD 3,210 The average price that the ETF previously sold MRNA share for is USD 40.8571 which is higher than the selling price of USD 26.67 on 2025-06-13. |
| UHS - Universal Health Services Inc | SELL | -62 @ USD 171.07 | USD -10,606 | The ETF sold 62 shares of UHS on 2025-06-13. The shares were previously bought for an average price of USD 189.072. The Universal Health Services Inc shares were sold for -9.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,116 The average price that the ETF previously sold UHS share for is USD 192.147 which is higher than the selling price of USD 171.07 on 2025-06-13. |
| SOLV - Solventum Corp. | SELL | -148 @ USD 73.8 | USD -10,922 | The ETF sold 148 shares of SOLV on 2025-06-13. The shares were previously bought for an average price of USD 74.1474. The Solventum Corp. shares were sold for -0.5% lower than average price of previous purchases. This resulted in an overall loss of USD 51 The average price that the ETF previously sold SOLV share for is USD 70.4636 so the ETF has sold 148 shares on 2025-06-13 at a higher price than the previous selling average. |
| VTRS - Viatris Inc | SELL | -1,336 @ USD 8.92 | USD -11,917 | The ETF sold 1336 shares of VTRS on 2025-06-13. The shares were previously bought for an average price of USD 10.3985. The Viatris Inc shares were sold for -14.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,975 The average price that the ETF previously sold VTRS share for is USD 11.9585 which is higher than the selling price of USD 8.92 on 2025-06-13. |
| INCY - Incyte Corporation | SELL | -178 @ USD 67.75 | USD -12,060 | The ETF sold 178 shares of INCY on 2025-06-13. The shares were previously bought for an average price of USD 69.0067. The Incyte Corporation shares were sold for -1.8% lower than average price of previous purchases. This resulted in an overall loss of USD 224 The average price that the ETF previously sold INCY share for is USD 72.2404 which is higher than the selling price of USD 67.75 on 2025-06-13. |
| RVTY - Revvity Inc. | SELL | -136 @ USD 93.53 | USD -12,720 | The ETF sold 136 shares of RVTY on 2025-06-13. The shares were previously bought for an average price of USD 111.979. The Revvity Inc. shares were sold for -16.5% lower than average price of previous purchases. This resulted in an overall loss of USD 2,509 The average price that the ETF previously sold RVTY share for is USD 112.822 which is higher than the selling price of USD 93.53 on 2025-06-13. |
| ALGN - Align Technology Inc | SELL | -78 @ USD 177.85 | USD -13,872 | The ETF sold 78 shares of ALGN on 2025-06-13. The shares were previously bought for an average price of USD 188.268. The Align Technology Inc shares were sold for -5.5% lower than average price of previous purchases. This resulted in an overall loss of USD 813 The average price that the ETF previously sold ALGN share for is USD 213.404 which is higher than the selling price of USD 177.85 on 2025-06-13. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -224 @ USD 69.7 | USD -15,613 | The ETF sold 224 shares of COO on 2025-06-13. The shares were previously bought for an average price of USD 89.0886. The The Cooper Companies, Inc. Common Stock shares were sold for -21.8% lower than average price of previous purchases. This resulted in an overall loss of USD 4,343 The average price that the ETF previously sold COO share for is USD 94.9249 which is higher than the selling price of USD 69.7 on 2025-06-13. |
| HOLX - Hologic Inc | SELL | -248 @ USD 64.75 | USD -16,058 | The ETF sold 248 shares of HOLX on 2025-06-13. The shares were previously bought for an average price of USD 66.9002. The Hologic Inc shares were sold for -3.2% lower than average price of previous purchases. This resulted in an overall loss of USD 533 The average price that the ETF previously sold HOLX share for is USD 71.6866 which is higher than the selling price of USD 64.75 on 2025-06-13. |
| BAX - Baxter International Inc | SELL | -560 @ USD 30.62 | USD -17,147 | The ETF sold 560 shares of BAX on 2025-06-13. The shares were previously bought for an average price of USD 33.3208. The Baxter International Inc shares were sold for -8.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,512 The average price that the ETF previously sold BAX share for is USD 32.3591 which is higher than the selling price of USD 30.62 on 2025-06-13. |
| WST - West Pharmaceutical Services Inc | SELL | -78 @ USD 221.91 | USD -17,309 | The ETF sold 78 shares of WST on 2025-06-13. The shares were previously bought for an average price of USD 256.3. The West Pharmaceutical Services Inc shares were sold for -13.4% lower than average price of previous purchases. This resulted in an overall loss of USD 2,682 The average price that the ETF previously sold WST share for is USD 299.806 which is higher than the selling price of USD 221.91 on 2025-06-13. |
| MOH - MOH | SELL | -60 @ USD 298.14 | USD -17,888 | The ETF sold 60 shares of MOH on 2025-06-13. The shares were previously bought for an average price of USD 309.477. The MOH shares were sold for -3.7% lower than average price of previous purchases. This resulted in an overall loss of USD 680 The average price that the ETF previously sold MOH share for is USD 306.496 which is higher than the selling price of USD 298.14 on 2025-06-13. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -60 @ USD 298.14 | USD -17,888 | The ETF sold 60 shares of MOH on 2025-06-13. The shares were previously bought for an average price of USD 309.477. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -3.7% lower than average price of previous purchases. This resulted in an overall loss of USD 680 The average price that the ETF previously sold MOH share for is USD 306.496 which is higher than the selling price of USD 298.14 on 2025-06-13. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -218 @ USD 91.28 | USD -19,899 | The ETF sold 218 shares of ZBH on 2025-06-13. The shares were previously bought for an average price of USD 107.101. The Zimmer Biomet Holdings Inc shares were sold for -14.8% lower than average price of previous purchases. This resulted in an overall loss of USD 3,449 The average price that the ETF previously sold ZBH share for is USD 106.678 which is higher than the selling price of USD 91.28 on 2025-06-13. |
| BIIB - Biogen Inc | SELL | -160 @ USD 130.65 | USD -20,904 | The ETF sold 160 shares of BIIB on 2025-06-13. The shares were previously bought for an average price of USD 145.643. The Biogen Inc shares were sold for -10.3% lower than average price of previous purchases. This resulted in an overall loss of USD 2,399 The average price that the ETF previously sold BIIB share for is USD 156.247 which is higher than the selling price of USD 130.65 on 2025-06-13. |
| WAT - Waters Corporation | SELL | -64 @ USD 342.3 | USD -21,907 | The ETF sold 64 shares of WAT on 2025-06-13. The shares were previously bought for an average price of USD 369.261. The Waters Corporation shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,726 The average price that the ETF previously sold WAT share for is USD 371.202 which is higher than the selling price of USD 342.3 on 2025-06-13. |
| WAT - MULETFWATIMETFP | SELL | -64 @ USD 342.3 | USD -21,907 | The ETF sold 64 shares of WAT on 2025-06-13. The shares were previously bought for an average price of USD 369.261. The MULETFWATIMETFP shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,726 The average price that the ETF previously sold WAT share for is USD 371.202 which is higher than the selling price of USD 342.3 on 2025-06-13. |
| DGX - Quest Diagnostics Incorporated | SELL | -124 @ USD 180.21 | USD -22,346 | The ETF sold 124 shares of DGX on 2025-06-13. The shares were previously bought for an average price of USD 167.015. The Quest Diagnostics Incorporated shares were sold for 7.9% higher than average price of previous purchases. This sale made a profit of USD 1,636 The average price that the ETF previously sold DGX share for is USD 160.472 so the ETF has sold 124 shares on 2025-06-13 at a higher price than the previous selling average. |
| PODD - Insulet Corporation | SELL | -76 @ USD 304.63 | USD -23,152 | The ETF sold 76 shares of PODD on 2025-06-13. The shares were previously bought for an average price of USD 268.184. The Insulet Corporation shares were sold for 13.6% higher than average price of previous purchases. This sale made a profit of USD 2,770 The average price that the ETF previously sold PODD share for is USD 265.365 so the ETF has sold 76 shares on 2025-06-13 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -90 @ USD 261.12 | USD -23,501 | The ETF sold 90 shares of LH on 2025-06-13. The shares were previously bought for an average price of USD 241.284. The Laboratory Corporation of America Holdings shares were sold for 8.2% higher than average price of previous purchases. This sale made a profit of USD 1,785 The average price that the ETF previously sold LH share for is USD 236.932 so the ETF has sold 90 shares on 2025-06-13 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -22 @ USD 1155.42 | USD -25,419 | The ETF sold 22 shares of MTD on 2025-06-13. The shares were previously bought for an average price of USD 1239.38. The Mettler-Toledo International Inc shares were sold for -6.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,847 The average price that the ETF previously sold MTD share for is USD 1235.95 which is higher than the selling price of USD 1155.42 on 2025-06-13. |
| MTD - AMUNDI EUR GOV 710 | SELL | -22 @ USD 1155.42 | USD -25,419 | The ETF sold 22 shares of MTD on 2025-06-13. The shares were previously bought for an average price of USD 1239.38. The AMUNDI EUR GOV 710 shares were sold for -6.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,847 The average price that the ETF previously sold MTD share for is USD 1235.95 which is higher than the selling price of USD 1155.42 on 2025-06-13. |
| STE - STERIS plc | SELL | -110 @ USD 241.34 | USD -26,547 | The ETF sold 110 shares of STE on 2025-06-13. The shares were previously bought for an average price of USD 222.089. The STERIS plc shares were sold for 8.7% higher than average price of previous purchases. This sale made a profit of USD 2,118 The average price that the ETF previously sold STE share for is USD 216.959 so the ETF has sold 110 shares on 2025-06-13 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -184 @ USD 156.89 | USD -28,868 | The ETF sold 184 shares of IQV on 2025-06-13. The shares were previously bought for an average price of USD 191.616. The IQVIA Holdings Inc shares were sold for -18.1% lower than average price of previous purchases. This resulted in an overall loss of USD 6,390 The average price that the ETF previously sold IQV share for is USD 194.936 which is higher than the selling price of USD 156.89 on 2025-06-13. |
| CNC - Concurrent Technologies Plc | SELL | -552 @ USD 55.22 | USD -30,481 | The ETF sold 552 shares of CNC on 2025-06-13. The shares were previously bought for an average price of USD 60.1182. The Concurrent Technologies Plc shares were sold for -8.1% lower than average price of previous purchases. This resulted in an overall loss of USD 2,704 The average price that the ETF previously sold CNC share for is USD 59.9643 which is higher than the selling price of USD 55.22 on 2025-06-13. |
| HUM - Hummingbird Resources PLC | SELL | -132 @ USD 235.26 | USD -31,054 | The ETF sold 132 shares of HUM on 2025-06-13. The shares were previously bought for an average price of USD 270.038. The Hummingbird Resources PLC shares were sold for -12.9% lower than average price of previous purchases. This resulted in an overall loss of USD 4,591 The average price that the ETF previously sold HUM share for is USD 274.96 which is higher than the selling price of USD 235.26 on 2025-06-13. |
| HUM - Humana Inc | SELL | -132 @ USD 235.26 | USD -31,054 | The ETF sold 132 shares of HUM on 2025-06-13. The shares were previously bought for an average price of USD 270.038. The Humana Inc shares were sold for -12.9% lower than average price of previous purchases. This resulted in an overall loss of USD 4,591 The average price that the ETF previously sold HUM share for is USD 274.96 which is higher than the selling price of USD 235.26 on 2025-06-13. |
| DXCM - DexCom Inc | SELL | -434 @ USD 81.99 | USD -35,584 | The ETF sold 434 shares of DXCM on 2025-06-13. The shares were previously bought for an average price of USD 77.8843. The DexCom Inc shares were sold for 5.3% higher than average price of previous purchases. This sale made a profit of USD 1,782 The average price that the ETF previously sold DXCM share for is USD 76.0804 so the ETF has sold 434 shares on 2025-06-13 at a higher price than the previous selling average. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -502 @ USD 72.25 | USD -36,270 | The ETF sold 502 shares of GEHC on 2025-06-13. The shares were previously bought for an average price of USD 84.8343. The GE HealthCare Technologies Inc. shares were sold for -14.8% lower than average price of previous purchases. This resulted in an overall loss of USD 6,317 The average price that the ETF previously sold GEHC share for is USD 80.7154 which is higher than the selling price of USD 72.25 on 2025-06-13. |
| A - Agilent Technologies Inc | SELL | -314 @ USD 117.08 | USD -36,763 | The ETF sold 314 shares of A on 2025-06-13. The shares were previously bought for an average price of USD 128.911. The Agilent Technologies Inc shares were sold for -9.2% lower than average price of previous purchases. This resulted in an overall loss of USD 3,715 The average price that the ETF previously sold A share for is USD 131.659 which is higher than the selling price of USD 117.08 on 2025-06-13. |
| RMD - ResMed Inc | SELL | -162 @ USD 249.34 | USD -40,393 | The ETF sold 162 shares of RMD on 2025-06-13. The shares were previously bought for an average price of USD 234.22. The ResMed Inc shares were sold for 6.5% higher than average price of previous purchases. This sale made a profit of USD 2,449 The average price that the ETF previously sold RMD share for is USD 240.57 so the ETF has sold 162 shares on 2025-06-13 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -268 @ USD 161.41 | USD -43,258 | The ETF sold 268 shares of CAH on 2025-06-13. The shares were previously bought for an average price of USD 128.331. The Cardinal Health Inc shares were sold for 25.8% higher than average price of previous purchases. This sale made a profit of USD 8,865 The average price that the ETF previously sold CAH share for is USD 124.119 so the ETF has sold 268 shares on 2025-06-13 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -88 @ USD 522.7 | USD -45,998 | The ETF sold 88 shares of IDXX on 2025-06-13. The shares were previously bought for an average price of USD 440.802. The IDEXX Laboratories Inc shares were sold for 18.6% higher than average price of previous purchases. This sale made a profit of USD 7,207 The average price that the ETF previously sold IDXX share for is USD 432.3 so the ETF has sold 88 shares on 2025-06-13 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -652 @ USD 75.15 | USD -48,998 | The ETF sold 652 shares of EW on 2025-06-13. The shares were previously bought for an average price of USD 71.2794. The Edwards Lifesciences Corp shares were sold for 5.4% higher than average price of previous purchases. This sale made a profit of USD 2,524 The average price that the ETF previously sold EW share for is USD 70.6398 so the ETF has sold 652 shares on 2025-06-13 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -318 @ USD 172.21 | USD -54,763 | The ETF sold 318 shares of BDX on 2025-06-13. The shares were previously bought for an average price of USD 226.588. The Becton Dickinson and Company shares were sold for -24.0% lower than average price of previous purchases. This resulted in an overall loss of USD 17,292 The average price that the ETF previously sold BDX share for is USD 220.904 which is higher than the selling price of USD 172.21 on 2025-06-13. |
| COR - Cencora Inc. | SELL | -190 @ USD 295.54 | USD -56,153 | The ETF sold 190 shares of COR on 2025-06-13. The shares were previously bought for an average price of USD 254.646. The Cencora Inc. shares were sold for 16.1% higher than average price of previous purchases. This sale made a profit of USD 7,770 The average price that the ETF previously sold COR share for is USD 248.403 so the ETF has sold 190 shares on 2025-06-13 at a higher price than the previous selling average. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -116 @ USD 529.24 | USD -61,392 | The ETF sold 116 shares of REGN on 2025-06-13. The shares were previously bought for an average price of USD 704.506. The Regeneron Pharmaceuticals Inc shares were sold for -24.9% lower than average price of previous purchases. This resulted in an overall loss of USD 20,331 The average price that the ETF previously sold REGN share for is USD 738.514 which is higher than the selling price of USD 529.24 on 2025-06-13. |
| HCA - HCA Holdings Inc | SELL | -196 @ USD 371.18 | USD -72,751 | The ETF sold 196 shares of HCA on 2025-06-13. The shares were previously bought for an average price of USD 337.989. The HCA Holdings Inc shares were sold for 9.8% higher than average price of previous purchases. This sale made a profit of USD 6,505 The average price that the ETF previously sold HCA share for is USD 329.427 so the ETF has sold 196 shares on 2025-06-13 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -494 @ USD 164.33 | USD -81,179 | The ETF sold 494 shares of ZTS on 2025-06-13. The shares were previously bought for an average price of USD 167.219. The Zoetis Inc shares were sold for -1.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,427 The average price that the ETF previously sold ZTS share for is USD 171.186 which is higher than the selling price of USD 164.33 on 2025-06-13. |
| CI - Cigna Corp | SELL | -302 @ USD 317.4 | USD -95,855 | The ETF sold 302 shares of CI on 2025-06-13. The shares were previously bought for an average price of USD 316.767. The Cigna Corp shares were sold for 0.2% higher than average price of previous purchases. This sale made a profit of USD 191 The average price that the ETF previously sold CI share for is USD 312.855 so the ETF has sold 302 shares on 2025-06-13 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -254 @ USD 384.55 | USD -97,676 | The ETF sold 254 shares of ELV on 2025-06-13. The shares were previously bought for an average price of USD 410.75. The Elevance Health Inc shares were sold for -6.4% lower than average price of previous purchases. This resulted in an overall loss of USD 6,655 The average price that the ETF previously sold ELV share for is USD 401.362 which is higher than the selling price of USD 384.55 on 2025-06-13. |
| ELV - Elevance Health Inc | SELL | -254 @ USD 384.55 | USD -97,676 | The ETF sold 254 shares of ELV on 2025-06-13. The shares were previously bought for an average price of USD 410.75. The Elevance Health Inc shares were sold for -6.4% lower than average price of previous purchases. This resulted in an overall loss of USD 6,655 The average price that the ETF previously sold ELV share for is USD 401.362 which is higher than the selling price of USD 384.55 on 2025-06-13. |
| MCK - McKesson Corporation | SELL | -138 @ USD 728.2 | USD -100,492 | The ETF sold 138 shares of MCK on 2025-06-13. The shares were previously bought for an average price of USD 621.578. The McKesson Corporation shares were sold for 17.2% higher than average price of previous purchases. This sale made a profit of USD 14,714 The average price that the ETF previously sold MCK share for is USD 607.576 so the ETF has sold 138 shares on 2025-06-13 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -2,246 @ USD 49.75 | USD -111,739 | The ETF sold 2246 shares of BMY on 2025-06-13. The shares were previously bought for an average price of USD 57.3147. The Bloomsbury Publishing Plc shares were sold for -13.2% lower than average price of previous purchases. This resulted in an overall loss of USD 16,990 The average price that the ETF previously sold BMY share for is USD 56.0365 which is higher than the selling price of USD 49.75 on 2025-06-13. |
| MDT - Medtronic PLC | SELL | -1,416 @ USD 87.27 | USD -123,574 | The ETF sold 1416 shares of MDT on 2025-06-13. The shares were previously bought for an average price of USD 88.7467. The Medtronic PLC shares were sold for -1.7% lower than average price of previous purchases. This resulted in an overall loss of USD 2,091 The average price that the ETF previously sold MDT share for is USD 85.4659 so the ETF has sold 1416 shares on 2025-06-13 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -282 @ USD 455.45 | USD -128,437 | The ETF sold 282 shares of VRTX on 2025-06-13. The shares were previously bought for an average price of USD 478.652. The Vertex Pharmaceuticals Inc shares were sold for -4.8% lower than average price of previous purchases. This resulted in an overall loss of USD 6,543 The average price that the ETF previously sold VRTX share for is USD 462.717 which is higher than the selling price of USD 455.45 on 2025-06-13. |
| DHR - Danaher Corporation | SELL | -706 @ USD 200.67 | USD -141,673 | The ETF sold 706 shares of DHR on 2025-06-13. The shares were previously bought for an average price of USD 216.682. The Danaher Corporation shares were sold for -7.4% lower than average price of previous purchases. This resulted in an overall loss of USD 11,304 The average price that the ETF previously sold DHR share for is USD 229.489 which is higher than the selling price of USD 200.67 on 2025-06-13. |
| DHR - Danaher Corporation | SELL | -706 @ USD 200.67 | USD -141,673 | The ETF sold 706 shares of DHR on 2025-06-13. The shares were previously bought for an average price of USD 216.682. The Danaher Corporation shares were sold for -7.4% lower than average price of previous purchases. This resulted in an overall loss of USD 11,304 The average price that the ETF previously sold DHR share for is USD 229.489 which is higher than the selling price of USD 200.67 on 2025-06-13. |
| SYK - Stryker Corporation | SELL | -378 @ USD 377.3 | USD -142,619 | The ETF sold 378 shares of SYK on 2025-06-13. The shares were previously bought for an average price of USD 379.729. The Stryker Corporation shares were sold for -0.6% lower than average price of previous purchases. This resulted in an overall loss of USD 918 The average price that the ETF previously sold SYK share for is USD 375.427 so the ETF has sold 378 shares on 2025-06-13 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -1,378 @ USD 109.98 | USD -151,552 | The ETF sold 1378 shares of GILD on 2025-06-13. The shares were previously bought for an average price of USD 102.991. The Guild Esports Plc shares were sold for 6.8% higher than average price of previous purchases. This sale made a profit of USD 9,631 The average price that the ETF previously sold GILD share for is USD 95.2403 so the ETF has sold 1378 shares on 2025-06-13 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -6,266 @ USD 24.54 | USD -153,768 | The ETF sold 6266 shares of PFE on 2025-06-13. The shares were previously bought for an average price of USD 25.8066. The Pfizer Inc shares were sold for -4.9% lower than average price of previous purchases. This resulted in an overall loss of USD 7,937 The average price that the ETF previously sold PFE share for is USD 25.8085 which is higher than the selling price of USD 24.54 on 2025-06-13. |
| BSX - Boston Scientific Corporation | SELL | -1,628 @ USD 99.74 | USD -162,377 | The ETF sold 1628 shares of BSX on 2025-06-13. The shares were previously bought for an average price of USD 98.6851. The Boston Scientific Corporation shares were sold for 1.1% higher than average price of previous purchases. This sale made a profit of USD 1,717 The average price that the ETF previously sold BSX share for is USD 91.1445 so the ETF has sold 1628 shares on 2025-06-13 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -1,628 @ USD 99.74 | USD -162,377 | The ETF sold 1628 shares of BSX on 2025-06-13. The shares were previously bought for an average price of USD 98.6851. The MULSTRXSSXIMETFP shares were sold for 1.1% higher than average price of previous purchases. This sale made a profit of USD 1,717 The average price that the ETF previously sold BSX share for is USD 91.1445 so the ETF has sold 1628 shares on 2025-06-13 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -422 @ USD 402.76 | USD -169,965 | The ETF sold 422 shares of TMO on 2025-06-13. The shares were previously bought for an average price of USD 521.751. The Time Out Group plc shares were sold for -22.8% lower than average price of previous purchases. This resulted in an overall loss of USD 50,214 The average price that the ETF previously sold TMO share for is USD 515.608 which is higher than the selling price of USD 402.76 on 2025-06-13. |
| AMGN - Amgen Inc | SELL | -592 @ USD 295.22 | USD -174,770 | The ETF sold 592 shares of AMGN on 2025-06-13. The shares were previously bought for an average price of USD 303.22. The Amgen Inc shares were sold for -2.6% lower than average price of previous purchases. This resulted in an overall loss of USD 4,736 The average price that the ETF previously sold AMGN share for is USD 288.886 so the ETF has sold 592 shares on 2025-06-13 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -392 @ USD 512.18 | USD -200,775 | The ETF sold 392 shares of ISRG on 2025-06-13. The shares were previously bought for an average price of USD 541.1. The Intuitive Surgical Inc shares were sold for -5.3% lower than average price of previous purchases. This resulted in an overall loss of USD 11,337 The average price that the ETF previously sold ISRG share for is USD 531.171 which is higher than the selling price of USD 512.18 on 2025-06-13. |
| MRK - Marks Electrical Group PLC | SELL | -2,798 @ USD 81.71 | USD -228,625 | The ETF sold 2798 shares of MRK on 2025-06-13. The shares were previously bought for an average price of USD 91.8712. The Marks Electrical Group PLC shares were sold for -11.1% lower than average price of previous purchases. This resulted in an overall loss of USD 28,431 The average price that the ETF previously sold MRK share for is USD 97.4899 which is higher than the selling price of USD 81.71 on 2025-06-13. |
| MRK - Merck & Company Inc | SELL | -2,798 @ USD 81.71 | USD -228,625 | The ETF sold 2798 shares of MRK on 2025-06-13. The shares were previously bought for an average price of USD 91.8712. The Merck & Company Inc shares were sold for -11.1% lower than average price of previous purchases. This resulted in an overall loss of USD 28,431 The average price that the ETF previously sold MRK share for is USD 97.4899 which is higher than the selling price of USD 81.71 on 2025-06-13. |
| ABT - Abbott Laboratories | SELL | -1,918 @ USD 135.62 | USD -260,119 | The ETF sold 1918 shares of ABT on 2025-06-13. The shares were previously bought for an average price of USD 127.034. The Abbott Laboratories shares were sold for 6.8% higher than average price of previous purchases. This sale made a profit of USD 16,468 The average price that the ETF previously sold ABT share for is USD 118.662 so the ETF has sold 1918 shares on 2025-06-13 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -1,014 @ USD 313.53 | USD -317,919 | The ETF sold 1014 shares of UNH on 2025-06-13. The shares were previously bought for an average price of USD 524.136. The UnitedHealth Group Incorporated shares were sold for -40.2% lower than average price of previous purchases. This resulted in an overall loss of USD 213,554 The average price that the ETF previously sold UNH share for is USD 542.614 which is higher than the selling price of USD 313.53 on 2025-06-13. |
| ABBV - AbbVie Inc | SELL | -1,942 @ USD 191.08 | USD -371,077 | The ETF sold 1942 shares of ABBV on 2025-06-13. The shares were previously bought for an average price of USD 193.556. The AbbVie Inc shares were sold for -1.3% lower than average price of previous purchases. This resulted in an overall loss of USD 4,808 The average price that the ETF previously sold ABBV share for is USD 185.188 so the ETF has sold 1942 shares on 2025-06-13 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -2,646 @ USD 157.1 | USD -415,687 | The ETF sold 2646 shares of JNJ on 2025-06-13. The shares were previously bought for an average price of USD 157.979. The Johnson & Johnson shares were sold for -0.6% lower than average price of previous purchases. This resulted in an overall loss of USD 2,326 The average price that the ETF previously sold JNJ share for is USD 152.68 so the ETF has sold 2646 shares on 2025-06-13 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -860 @ USD 819.36 | USD -704,650 | The ETF sold 860 shares of LLY on 2025-06-13. The shares were previously bought for an average price of USD 837.646. The Eli Lilly and Company shares were sold for -2.2% lower than average price of previous purchases. This resulted in an overall loss of USD 15,726 The average price that the ETF previously sold LLY share for is USD 793.09 so the ETF has sold 860 shares on 2025-06-13 at a higher price than the previous selling average. |